A national consortium of universities, hospitals and industry, led by Monash University and BiVACOR, have received $1 million from the MRFF, to develop and commercialise a world-first durable Total Artificial Heart.
The BiVACOR Total Artificial Heart shown in the chest cavity (left) and
transparent image demonstrating the capacity to support the whole heart (right).
Heart failure is an epidemic that impacts more than 300,000 Australians. There is a clear gap in the market for patient-friendly devices to provide a solution to this chronic health challenge.
The research team seeks to take this new artificial heart technology to market within the six-year duration of MRFF Frontiers program. See full story